Kalbe Farma Grew By 1.41% in YTD September 2006

PT Kalbe Farma Tbk. (“Company”) today announced financial results for the quarter ended Sep 30, 2006.

Throughout the period of nine months of 2006, the Company sales performance has increased by 1.41% to Rp 4.49 trillion versus Rp 4.43 trillion last year.

Gross profit margin increased from 50.9% of Net Sales from last year to become 51% of Net Sales for the nine months period of 2006. This is due to the favorable and stable US Dollar exchange rate resulting in favorable cost of raw material that is mostly imported.

Operating expense increased by 5.27% compared to the same period last year. The Company will further make utmost efforts to minimize its expenses particularly its selling expenses so as to be in proportion with its sales growth towards the year end.

Operating Profit reached Rp 853 billion which is 4.11% lower than the previous year’s which was Rp 890 billion. Operating profit ratio decreased from 20.1% of Net Sales to become 19% of Net Sales this year.

However, the Company posted net profit of Rp 540 billion; 5.71% higher than 2005’s figure which was Rp 511 billion. The growth is mainly contributed by the increase in interest income, decrease in financial expenses and the reduction in foreign exchange loss.